Details for Patent: 6,855,703
Summary for Patent: 6,855,703
| Title: | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
| Abstract: | A composition of matter is provided having a mixture of active estrogenic compounds. The mixture is present in chemically pure form. The mixture includes salts of conjugated estrone, conjugated equilin, conjugated Δ8,9-dehydroestrone, conjugated 17α-estradiol, conjugated 17α-dihydroequilin, conjugated 17β-dihydroequilin, conjugated 17β-estradiol, conjugated equilenin, conjugated 17α-dihydroequilenin, and conjugated 17β-dihydroequilenin. The mixture also contains the same essential estrogenic compounds present in naturally derived equine conjugated estrogens. Drug products including the composition of matter are also provided, as are methods of using these drug products to treat mammals in need of treatment. Methods of analyzing mixtures containing conjugated estrogens are also provided. |
| Inventor(s): | Edward N. Hill, Thomas W. Leonard, Frederick D. Sancilio, Katherin M. Schlipp, Dean G. Shirazi, Robert R. Whittle |
| Assignee: | Teva Womens Health Inc |
| Application Number: | US09/524,132 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,855,703 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 6,855,703
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,855,703
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2001245417 | ⤷ Start Trial | |||
| Australia | 4541701 | ⤷ Start Trial | |||
| Canada | 2402559 | ⤷ Start Trial | |||
| European Patent Office | 1267852 | ⤷ Start Trial | |||
| Japan | 2004500396 | ⤷ Start Trial | |||
| Japan | 2011256181 | ⤷ Start Trial | |||
| South Korea | 100804224 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
